LexDanaLexDanabeta
Inventor

ANDREW JOHN MCKNIGHT

Inventor
US

Overview

3→
Patents
2024–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
C07KPeptides38%
A61KPreparations for medical, dental or toiletry purposes25%
PatentTitleYear
12,391,761Antibodies directed against interleukin 36 receptor (IL-36R)202512,234,292FN14 antibodies and uses thereof202511,999,783Method of treating autoimmune disease with antibodies against IL-332024

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2024–2025Patents assigned to ANAPTYSBIO INC (2)· patent assignee history
2024–2025Based in US· patent location history
2025Patents assigned to KYOWA KIRIN CO LTD (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ANAPTYSBIO INC22024–2025
KYOWA KIRIN CO LTD12025
Locations
LocationPatentsSpan
US32024–2025